Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 1817080 absolute and relative bioavailability food-effect crossover study in healthy volunteers
NL-OMON46143Completed
- Sponsor
- Bayer
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of eliapixant in chronic cough (3 arms), sponsored by Bayer. Primary endpoints: Absolute bioavailability and pharmacokinetics of BAY 1817080 and Relative bioavailability of formulations under different diet conditions. Started Nov 2018; status: completed.
02
Drugs
eliapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NL-OMON46143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46143.